The growing global demand for pharmaceuticals due to longer, more affluent living, presents many challenges for the industry. While the Life Sciences and Healthcare industry aims to improve the quality of our longer lives, there is a growing recognition that the pharmaceutical sector must do more to improve its sustainability performance.
To meet the high demands of sustainability, traditional ways of innovating will not affect manufacturing sustainability quickly or effectively enough. Instead, manufacturers need to leverage the power of the virtual twin to optimize their real-world impact before building their plants and supply network.
Virtual twins are a crucial solution to solve complex pharmaceutical manufacturing sustainability challenges, such as achieving zero carbon and integrating more closely with the circular economy.